Healthy Skepticism Library item: 6653

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Potts R, Vitry A.
Re: the promotion of Plaquenil (hydroxychloroquine)
1996 Feb;

Abstract:

Sanofi Winthrop is claiming that Plaquenil (hydroxychloroquine) can prevent long-term damage due to rheumatiod arthritis and that it has a low incidence of side effects. The scientific literature raises doubts about both of these claims.

Keywords:
*analysis/Australia/developed countries/Plaquenil/hydroxychloroquine/Sanofi Winthrop/arthritis/safety & risk information/MaLAM/Medical Lobby for Appropriate Marketing/quality of information/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES